Xizang Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. It offers capsules, tablets, granules, and bulk drugs in the fields of cardiovascular, liver disease, diabetes, anti-infection, digestive system, hematological system, nervous and mental system, parenteral nutrition, first-aid, antibiotics, and tumor adjuvant applications. The company’s products include invert sugar, sodium fusidate, polyene phosphatidylcholine, and fat-soluble vitamins. It also develops nalmefene hydrochloride, dolasetron mesylate, cefodizime sodium, and compound amino acids. The company was founded in 2000 and is based in Chengdu, China.
xizang haisco pharmaceutic-a
(002653:Shenzhen Stock Exchange)
Taiwan Strait Technology Industry Development Park
No. 136, Beverley Road
Phone: 86 89 3783 4865
|No competitor information is available for 002653.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact XIZANG HAISCO PHARMACEUTIC-A, please visit www.haisco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.